More than 70 countries at risk of running out of HIV drugs due to coronavirus pandemic, WHO says

spike

File Photo: Patients, some HIV-positive, and their relatives protest for the lack of medicines and medical supplies in hospitals, in front of the Health Ministry in Caracas on April 18, 2018.

Luis Robayo | AFP | Getty Images

More than 70 countries warned they are at risk of running out of HIV medication due to the coronavirus pandemic, according to a survey conducted by the World Health Organization.

Twenty-four countries said they have a “critically low” stock of antiretroviral medicine, or ARVs, largely used as a therapy to treat HIV, or have seen a disruption in their supply chain as

Read More

Lancet retracts Covid-19 paper that raised safety concerns about drugs

spike

A pharmacy tech holds a bottle and a pill of Hydroxychloroquine at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020.

George Frey | Getty Images

The Lancet, one of the world’s top medical journals, on Thursday retracted an influential study that raised alarms about the safety of the experimental Covid-19 treatments chloroquine and hydroxychloroquine amid scrutiny of the data underlying the paper.

The retraction came at the request of the authors of the study, published last month, who were not directly involved with the data collection and sources, the journal said.

“We can no longer vouch for the

Read More

Here are the top drugs and vaccines in development

spike

A researcher of the Openlab genetic and cell technologies laboratory of the Kazan Federal University working with biomaterial.

Yegor Aleyev | TASS via Getty Images

Health officials and scientists across the world are racing to develop vaccines and discover effective treatments against the coronavirus, which has infected more than 4.2 million people worldwide in as little as four months, according to data compiled by Johns Hopkins University.

There are no proven, knockout treatments and U.S. health officials say a vaccine could take at least a year to 18 months.

On May 1, the Food and Drug Administration granted emergency use

Read More

Gilead’s shares rise on report of experimental drug’s promise in COVID-19

spike

(Reuters) – Shares of Gilead Sciences Inc rose 10% in early trading on Friday after a report that patients with COVID-19 treated with the company’s experimental drug, remdesivir, in a clinical trial showed rapid recovery in fever and respiratory symptoms.

FILE PHOTO: A Gilead Sciences Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam

There are currently no approved treatments or vaccines for the coronavirus, which has infected 2.14 million globally, according to a Reuters tally, and remdesivir is one of the treatments that has captured investor’s attention.

But analysts and the company urged caution

Read More